Table 1. Description of demographic and clinical variables of patients with cystic fibrosis in relation to telemedicine care.
| Teleconsultation | ||||
|---|---|---|---|---|
| Total (n=184) | Yes (n=153) | No (n=310) | p-value | |
| Male | 87.0 (47.3) | 71 (46.4) | 16 (51.6) | 0.700 |
| Age (years) | 7.2±5.3 | 7.0±0.5 | 8.0±1.0 | 0.330 |
| Children | 137.0 (74.4) | 115.0 (75.1) | 22.0 (70.9) | 0.340 |
| Adolescents | 47.0 (25.5) | 38.0 (24.8) | 9.0 (29.0) | |
| % FEV1 | 78.5±20.5 | 77.6±21.1 | 83.3±17.3 | 0.270 |
| Mutations | ||||
| F508del/F508del | 39.0 (29.4) | 37.0 (31.1) | 2.0 (14.3) | 0.390 |
| F508del/other | 47.0 (35.3) | 42.0 (35.3) | 5.0 (35.7) | |
| Other mutations | 47.0 (35.3) | 40.0 (33.6) | 7.0 (50.0) | |
| Colonization | ||||
| Negative | 69.0 (37.7) | 47.0 (30.9) | 22.0 (71.0) | <0.001* |
| SA | 33.0 (18.0) | 31.0 (20.4) | 2.0 (6.5) | |
| NMPA | 19.0 (10.4) | 19.0 (12.5) | 0 | |
| MPA | 23.0 (12.6) | 18.0 (11.8) | 5.0 (16.0) | |
| MRSA | 17.0 (9.3) | 15.0 (9.9) | 2.0 (6.4) | |
| BCC | 22.0 (12.0) | 22.0 (14.5) | 0 | |
Variables expressed as n (%) or as mean±standard deviation. SA: Staphylococcus aureus; NMPA: non-mucoid Pseudomonas aeruginosa; MPA: mucoid Pseudomonas aeruginosa; MRSA: methicillin-resistant Staphylococcus aureus. BCC: Burkholderia cepacia complex. FEV1: forced expiratory volume in one second. *p<0.05.